FDA approves immune checkpoint inhibitor drug for patients with resectable locally advanced head and neck cancer, backed by Dana-Farber research
Business Announcement
Updates every hour. Last Updated: 14-Jun-2025 21:09 ET (15-Jun-2025 01:09 GMT/UTC)